Purpose: The aim of this study was to determine the impact of the presence of carcinoma in situ at the bile duct stump on postoperative survival in patients who underwent resection of extrahepatic bile duct carcinoma.
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INTRODUCTION
Many studies have reported positive surgical margins as an important predictor of poor prognosis in patients with extrahepatic bile duct carcinoma. [1] [2] [3] [4] [5] However, several reports have found that prognosis for patients with a positive bile duct stump does not differ significantly from that of carcinoma-negative patients, and some reports have even described long-term survival of patients with a positive surgical bile duct stump. 6, 7 In most studies dealing with the postoperative prognosis of extrahepatic bile duct carcinoma patients, status of the surgical bile duct stump has been histologically classified into only two categories: negative or positive. However, histologically positive surgical bile duct stumps can be further subclassified into two subtypes: invasive carcinoma and carcinoma in situ.
Extrahepatic bile duct carcinoma is sometimes associated with more than high-grade atypical intraepithelial cells that are continuously adjacent to the main tumour, representing what is called the superficial spread of extrahepatic bile duct carcinoma. [8] [9] [10] [11] [12] However, to the best of our knowledge, only three reports have described the impact of remnant carcinoma in situ at the bile duct stump on postoperative survival, [13] [14] [15] 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Nakanishi -4-
MATERIALS AND METHODS

Extrahepatic bile duct carcinoma patients
First, patients in whom the epithelium at the bile duct stump was exfoliated and the nearest epithelium represented carcinoma in situ were excluded from this study, since such patients were impossible to classify by surgical margin status. As a result, the population for this study comprised a total of 125 patients (100 men, 25 women) who underwent surgical resection for invasive extrahepatic bile duct carcinoma in the Second Department of Surgery, Hokkaido University Hospital between December 1989 and January 2007. Tumours arising from the ampulla of Vater and cystic duct were not included in this study.
Tissue preparation
All surgically resected specimens and intraoperative frozen sections of bile duct stumps, if performed, were fixed in 10% buffered formalin. Serial sections at 3-to 6-mm intervals were prepared from the entire area of the extrahepatic bile duct.
Classification of surgical margins
In this study, patients were classified into three groups according to resected margin status: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Nakanishi -5-Negative group (n=96); CIS group (n=10); and Invasive group (n=19). The CIS group comprised cases with carcinoma in situ at the bile duct stump, but no invasive carcinoma at any surgical margins. We defined carcinoma in situ as intraepithelial atypical cells showing cellular atypia corresponding to biliary intraepithelial neoplasia-3 (BilIN-3). 16 In all 10 cases classified into the CIS group, carcinoma in situ displayed continuity from the main tumour to the bile duct stump on serial surgical sections. The Invasive group comprised patients with invasive carcinoma at the surgical margins, including not only the bile duct stumps, but also the radial margins. Numbers of patients with invasive carcinoma at the bile duct stump, radial margin, and both bile duct and radial margin were 5, 8, and 6, respectively. Patients with both of carcinoma in situ at the bile duct stump and invasive carcinoma at the surgical margins were classified into the Invasive group. Surgical procedures for the three groups are shown in Table 1 .
Comparison of clinicopathological features
To identify differences among the three groups in clinicopathological features, various factors Nakanishi -6tumour were classified as "localising type" or "infiltrating type". "Localising type" was defined as the presence of protrusion into the bile duct lumen (for example, papillary or nodular appearance), while "infiltrating type" was defined as having an almost flat and sclerosing appearance. Predominant histological differentiation grade was classified as either well-differentiated (G1) or other (non-G1). International Union Against Cancer (UICC) criteria were used to classify pTNM. 17 Adjuvant therapy was not examined basically at our department. However, it was done by the judgement of the individual attending physicians at the follow-up hospitals.
Patient follow-up after surgical resection
The survival status of all patients was determined. All surviving patients were surveyed about their present condition by their follow-up medical support institutions. For non-surviving patients, causes of death were determined. In addition, for patients with recurrence, sites of initial recurrence were determined based on follow-up computed tomography (CT), magnetic resonance imaging (MRI), bone scintigraphy or autopsy findings, where available.
Survival analysis
Cause-specific survival curves for the three groups were determined using the Kaplan-Meier method, and differences among the three groups were examined statistically. Deaths with recurrence were treated as failure cases and deaths due to complications associated with the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Nakanishi -7operation or other disease without evidence of recurrence were treated as censored cases. To elucidate the effects of surgical margin status on postoperative survival, variables were compared on univariate analysis. In addition, multivariate analysis was performed to identify factors independently associated with post-resectional survival.
Statistical analysis
Variables were compared using Pearson's χ 2 test. Distributions of values were compared using the Mann-Whitney U test. Cause-specific survival curves were calculated using the Kaplan-Meier method, and the log-rank test was used to determine significant differences in survival. The Cox proportional hazards model was used for multivariate analysis. In this model, stepwise selection was used for variable selection with entry and removal limits of p<0.1 and p>0.15, respectively. All tests were two-sided and values of p<0.05 were considered statistically significant.
RESULTS
Comparison of clinicopathological features
The results of comparisons for clinicopathological features among the three groups according to resected margin status are shown in Table 2 . The CIS group predominantly showed less depth of invasion, absence of lymph nodes metastases, and localising type of gross 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Nakanishi -8appearance of the main tumour compared with the Negative and Invasive groups (p=0.009, p=0.031, and p=0.075, respectively). The number of patients with recurrence was 56 (58%) in the Negative group, 5 (50%) in the CIS group, and 16 (84%) in the Invasive group. All deaths with recurrence occurred ≤5 years after surgery, excluding two of three patients with local recurrence in the CIS group.
Survival after surgical resection
Cause-specific survival curves
Survival curves for the three groups are shown in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 and CIS groups (p=0.006).
In the CIS group, the incidences of pT1 or pT2, absence of lymph node metastasis, and localizing type of gross appearance of the main tumour were significant high. Therefore, we also examined the difference between the CIS and the Negative groups in survival in each subgroup classified by these factors to evaluate the effect of carcinoma in situ at ductal margin. As a result, the CIS group did not display difference compared to the Negative group in pT1 or pT2, absence lymph node metastasis, and localizing type of gross appearance of the main tumour subgroups (p=0.941, p=0.748, and p=0.714, respectively).
Uni-and multivariate survival analyses of clinicopathological features
Impacts of clinicopathological variables on cause-specific survival in all 125 patients are shown in Table 3 . Predominant histological differentiation of main tumour, lymph node metastasis, distant metastasis (all sites of which were para-aorta lymph nodes), venous vessel invasion, and surgical margin status were identified as prognostic factors on univariate analysis (p=0.010, p<0.001, p<0.001, p<0.001, and p=0.005, respectively). On multivariate analysis, predominant histological differentiation of main tumour, distant metastasis, venous vessel invasion, and surgical margin status represented independent prognostic factors (p=0.027, p=0.003, p<0.001, and p=0.018, respectively) ( Table 4 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Nakanishi -10-Initial recurrence sites in 71 patients with recurrence and detailed data for 10 patients with carcinoma in situ at the bile duct stump are shown in Tables 5 and 6, respectively. Sites were not determined for six patients because records were unavailable from follow-up hospitals.
Sites of recurrence
The most frequent sites of initial recurrence were local for the CIS (60%) and Invasive groups (44%), and in the liver (52%) for the Negative group. In the comparison of recurrence patterns (local vs. liver vs. other sites) among the three groups, recurrences in the CIS group tended to more frequently present as local recurrence compared to those in the Negative group (p=0.002, Pearson's χ 2 test).
In the CIS group, disease-free periods and postoperative survival periods for all three patients with local sites of initial recurrence were 29, 53 and 66 months, and 34, 75 and 70 months, respectively. Median disease-free period was 53 months for the three patients with initial local recurrence in the CIS group and 13 months (range, 4-38 months) for the 12 patients in the Invasive and Negative groups (p=0.014, Mann-Whitney U test). Median survival time until death was 70 months for the three CIS patients, compared to 17 months (range, 5-53 months) for the 12 patients in the Invasive and Negative groups (p=0.014, Mann-Whitney U test) (Figure 2) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Nakanishi -11-This study evaluated the impact of resected margin status, particularly as remnant carcinoma in situ, on post-resectional survival in patients with extrahepatic bile duct carcinoma. The result clarified that: 1) surgical margin status of remnant invasive carcinoma represents an independent prognosis factor; 2) survival for patients with remnant carcinoma in situ does not differ compared to survival for patients without remnant carcinoma; 3) patients with remnant carcinoma in situ or invasive carcinoma experience local recurrence more frequently than patients without remnant carcinoma; and 4) remnant carcinoma in situ is likely to cause local recurrence later in the postoperative phase compared to remnant invasive carcinoma.
DISCUSSION
Whether remnant carcinoma in situ at the bile duct stump develops into invasive carcinoma has been unclear. In this study, only 10 patients showed carcinoma in situ at the bile duct stump. However, in patients with recurrence, the frequency of local recurrence in the CIS group was 60%, representing a significant difference from the Negative group (p=0.002). We therefore believe that carcinoma in situ has the potential to progress to invasive carcinoma.
In extrahepatic bile duct carcinoma, major recurrence sites include the liver, lymph nodes, and local sites. Selection of the presence of venous vessel invasion, para-aortic lymph node metastasis, and surgical margin status as independent prognostic factors by multivariate analysis, as seen in the present study, is thus unsurprising. Patients with remnant invasive carcinoma at the resected margins had worse survival compared to those without remnant carcinoma, as previously reported, 1-4 but those with remnant carcinoma in situ did not. Two potential reasons for this phenomenon are as follows. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Nakanishi -12-First, the biological nature of main tumours with extensive superficial spread, which is likely to be responsible for remnant carcinoma in situ at the bile duct stump, tends to be less malignant compared to that of conventional cholangiocarcinoma. In our previous study 11 , main tumours of extrahepatic bile duct carcinoma with extensive superficial spread showed a tendency of shallower invasion, localising-type gross appearance, and good histological differentiation compared to conventional cholangiocarcinoma. These findings of cholangiocarcinoma with superficial spread have been reported in other two institutions. 12, 15 This suggests that the majority of superficial spread arises from main tumours with a low invasive nature. In addition, Igami et al. reported that venous invasion, lymph node metastasis, and distant metastasis were less frequent in cholangiocarcinoma with superficial spread than in cholangiocarcinoma without superficial spread. 12 Likewise, in the present study, the CIS group tended to show shallower invasion, localising-type gross appearance of main tumour, and absence of lymph nodes metastasis compared to tumours in the Negative and Invasive groups. These factors have been reported as better prognostic factors in several studies dealing with extrahepatic bile duct carcinoma. 7, 12, [18] [19] [20] Second, remnant carcinoma in situ is likely to develop into invasive carcinoma in the late phase after surgery. In this study, the CIS group did not display difference in survival compared to the Negative group even in pT1/2, absence of lymph node metastasis, and localising-type of main tumour subgroups. However, all deaths due to recurrence occurred ≤5 years after surgery, excluding the two cases with local recurrence in the CIS group . Wakai et   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 al. also reported that two of four patients with remnant carcinoma in situ died of local recurrence >5 years after surgery. 14 We have previously reported two patients in whom progression from remnant carcinoma in situ to recurrent invasive carcinoma required 9 and 12 years after the first surgery at another institutes. 8, 9 Ojima et al. reported that the period until anastomotic recurrence after surgical resection in patients with invasive carcinoma at bile duct resection margin was significantly shorter than that in patients with carcinoma in situ at the bile duct resection margin. 15 The less malignant nature of main tumours and slower growth of remnant carcinoma in situ thus seems responsible for the lack of difference in postoperative survival between the CIS and Negative groups.
Our previous study clarified that tumours accompanying extensive superficial spread are pathologically characterised by a localising-type gross appearance. 11 In addition, areas of carcinoma in situ showed low papillary growth histologically, corresponding to the granular mucosal surface on gross appearance. Some reports have suggested that area of superficial spread could be observed as a fine granular or papillary appearance on cholangioscopy. 21, 22 Since the granular mucosal surface is thought to be difficult to detect on routine imaging modalities such as abdominal ultrasonography, computed tomography, and cholangiography, particularly in patients with localising-type tumour, cholangioscopy and/or endoscopic biopsy may help determine the extent of carcinoma in situ.
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